Combination therapies in iron chelation

by Raffaella Origa
Published 2014-12-01

PREGNANCY IN THALASSEMIA

by Raffaella Origa, Federica Comitini
Published 2019-02-01

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previous...

by Immacolata Tartaglione, Raffaella Origa, Antonis Kattamis, Michael Pfeilstöcker, Sibel Gunes, Susanne Crowe, Niamh Fagan, Beatrice Vincenzi, Giovan Battista Ruffo
Published 2020-08-01

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

by Raffaella Origa, Giuseppe Marceddu, Fabrice Danjou, Luciana Perseu, Stefania Satta, Franca Rosa Demartis, Antonio Piga, Filomena Longo, Maria-Eliana Lai, Stefania Vacquer, Renzo Galanello
Published 2015-05-01

Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

by Ali T. Taher, Raffaella Origa, Silverio Perrotta, Alexandra Kouraklis, Giovan Battista Ruffo, Antonis Kattamis, Ai-Sim Goh, Vicky Huang, Aiesha Zia, Raquel Merino Herranz, John B. Porter
Published 2018-11-01

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

by Donatella Baronciani, Maddalena Casale, Lucia De Franceschi, Giovanna Graziadei, Filomena Longo, Raffaella Origa, Paolo Rigano, Valeria Pinto, Monia Marchetti, Antonia Gigante, Achille Iolascon, (on behalf of, & Chair of, the EHA Scientific Working Group on Red Cells and Iron), Gian Luca Forni
Published 2021-05-01